Determination of naltrexone and 6 beta-naltrexol in plasma by high-performance liquid chromatography with coulometric detection. 1991

P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
Istituto Superiore di Sanità, Rome, Italy.

A simple and reliable reversed-phase high-performance liquid chromatographic method with coulometric detection is described for the quantitation of naltrexone and its metabolite, 6 beta-naltrexol, in plasma samples of healthy volunteers who received orally 50 mg of naltrexone. The analytes and the internal standard, naloxone, are extracted with an octadecyl solid-phase extraction column before chromatography. The mobile phase is 0.01 M potassium phosphate (pH 3)-acetonitrile (85:15, v/v) and it is pumped at 0.8 ml/min. The coulometric detector is formed by two electrodes set at +0.20 V and +0.70 V, with a palladium reference electrode. The limit of quantitation observed was 5 ng/ml for both naltrexone and 6 beta-naltrexol. This method can be used to investigate pharmacokinetic parameters of different pharmaceutical preparations of this opioid antagonist.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004563 Electrochemistry The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes. Electrochemistries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
September 1996, Journal of pharmaceutical and biomedical analysis,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
October 1993, Journal of chromatography,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
April 1990, Journal of chromatography,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
August 2012, BMC research notes,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
April 1996, Journal of chromatography. B, Biomedical applications,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
January 1995, Journal of chromatography. B, Biomedical applications,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
January 1993, Journal of pharmaceutical and biomedical analysis,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
January 1980, Journal of analytical toxicology,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
January 1981, NIDA research monograph,
P Zuccaro, and I Altieri, and P Betto, and R Pacifici, and G Ricciarello, and L A Pini, and E Sternieri, and S Pichini
May 1986, Journal of chromatography,
Copied contents to your clipboard!